Rachel E. Behrman

1.5k total citations
12 papers, 854 citations indexed

About

Rachel E. Behrman is a scholar working on Infectious Diseases, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Rachel E. Behrman has authored 12 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Epidemiology and 4 papers in Economics and Econometrics. Recurrent topics in Rachel E. Behrman's work include Pharmaceutical Economics and Policy (4 papers), Pharmaceutical studies and practices (3 papers) and Tuberculosis Research and Epidemiology (2 papers). Rachel E. Behrman is often cited by papers focused on Pharmaceutical Economics and Policy (4 papers), Pharmaceutical studies and practices (3 papers) and Tuberculosis Research and Epidemiology (2 papers). Rachel E. Behrman collaborates with scholars based in United States and Israel. Rachel E. Behrman's co-authors include Janet Woodcock, Joseph P. Griffin, Richard Platt, Mark McClellan, Jeffrey S. Brown, Joshua S. Benner, Peter Nicholas, Joseph Masci, Leonard Sacks and Gerald J. Dal Pan and has published in prestigious journals such as New England Journal of Medicine, Nature Reviews Drug Discovery and Clinical Infectious Diseases.

In The Last Decade

Rachel E. Behrman

11 papers receiving 814 citations

Peers

Rachel E. Behrman
Nitin Mehrotra United States
Daniel Shepshelovich Israel
Stella G. Machado United States
Enrique Seoane‐Vazquez United States
Helen Kastrissios United States
Jim M. Koeller United States
Guy Montay France
Igor Tsaur Germany
J Oyee United Kingdom
Goonaseelan Pillai South Africa
Nitin Mehrotra United States
Rachel E. Behrman
Citations per year, relative to Rachel E. Behrman Rachel E. Behrman (= 1×) peers Nitin Mehrotra

Countries citing papers authored by Rachel E. Behrman

Since Specialization
Citations

This map shows the geographic impact of Rachel E. Behrman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Behrman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Behrman more than expected).

Fields of papers citing papers by Rachel E. Behrman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel E. Behrman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Behrman. The network helps show where Rachel E. Behrman may publish in the future.

Co-authorship network of co-authors of Rachel E. Behrman

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel E. Behrman. A scholar is included among the top collaborators of Rachel E. Behrman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel E. Behrman. Rachel E. Behrman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Woodcock, Janet, Joseph P. Griffin, & Rachel E. Behrman. (2011). Development of Novel Combination Therapies. New England Journal of Medicine. 364(11). 985–987. 211 indexed citations
2.
Behrman, Rachel E., Joshua S. Benner, Jeffrey S. Brown, et al.. (2011). Developing the Sentinel System — A National Resource for Evidence Development. New England Journal of Medicine. 364(6). 498–499. 253 indexed citations
3.
Woodcock, Janet, Rachel E. Behrman, & Gerald J. Dal Pan. (2010). Role of Postmarketing Surveillance in Contemporary Medicine. Annual Review of Medicine. 62(1). 1–10. 38 indexed citations
4.
Sacks, Leonard & Rachel E. Behrman. (2009). Challenges, Successes and Hopes in the Development of Novel Tb Therapeutics. Future Medicinal Chemistry. 1(4). 749–756. 18 indexed citations
5.
Sacks, Leonard & Rachel E. Behrman. (2008). Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective. Tuberculosis. 88. S93–S100. 29 indexed citations
6.
Lanthier, Michael, Rachel E. Behrman, & Clark Nardinelli. (2008). Economic issues with follow-on protein products. Nature Reviews Drug Discovery. 7(9). 733–737. 36 indexed citations
7.
Behrman, Rachel E., et al.. (2008). Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs. Drug Information Journal. 42(3). 273–279. 2 indexed citations
8.
Woodcock, Janet, Rachel E. Behrman, Barry Cherney, et al.. (2007). The FDA's assessment of follow-on protein products: a historical perspective. Nature Reviews Drug Discovery. 6(6). 437–442. 111 indexed citations
9.
Chapman, Louisa E., B. A. Ellis, Frederick Koster, et al.. (2002). Discriminators between Hantavirus-Infected and -Uninfected Persons Enrolled in a Trial of Intravenous Ribavirin for Presumptive Hantavirus Pulmonary Syndrome. Clinical Infectious Diseases. 34(3). 293–304. 35 indexed citations
10.
Behrman, Rachel E.. (1999). FDA approval of Antiretroviral Agents: An Evolving Paradigm. Drug Information Journal. 33(2). 337–341.
11.
Behrman, Rachel E., Joseph Masci, & Peter Nicholas. (1990). Cryptococcal Skeletal Infections: Case Report and Review. Clinical Infectious Diseases. 12(2). 181–190. 83 indexed citations
12.
Behrman, Rachel E.. (1989). Central Nervous System Infections in the Elderly. Archives of Internal Medicine. 149(7). 1596–1596. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nitin Mehrotra Breakdown of academic impact, for papers by Daniel Shepshelovich Breakdown of academic impact, for papers by Stella G. Machado Breakdown of academic impact, for papers by Enrique Seoane‐Vazquez Breakdown of academic impact, for papers by Helen Kastrissios Breakdown of academic impact, for papers by Jim M. Koeller Breakdown of academic impact, for papers by Guy Montay Breakdown of academic impact, for papers by Igor Tsaur Breakdown of academic impact, for papers by J Oyee Breakdown of academic impact, for papers by Goonaseelan Pillai
Rankless by CCL
2026